Stockreport

IO Biotech GAAP EPS of -$0.13 beats by $0.25 [Seeking Alpha]

IO Biotech, Inc.  (IOBT) 
PDF Ended the third quarter with approximately $31 million in cash and cash equivalents, which is expected to support operations through the first quarter of 2026 More on [Read more]